RecruitingNot ApplicableNCT04978571

Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)

A Prospective Study on the Effect of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)


Sponsor

Children's Hospital of Orange County

Enrollment

125 participants

Start Date

Feb 1, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to test the effect of Auricular Percutaneous Electrical Nerve Field Stimulation (a Neurostim device) on children with pain and Post Concussion symptoms. An additional purpose of this study is to demonstrate that PENFS improves functioning in children with post Covid-19 symptoms.


Eligibility

Min Age: 11 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called percutaneous electrical nerve-field stimulation, PENFS, percutaneous electrical nerve-field stimulation, PENFS (COVID active device), and others for people with covid long-haul, covid-19, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEpercutaneous electrical nerve-field stimulation, PENFS

A novel, FDA approved for commercial use, cleared device that delivers field stimulation with alternating frequencies to the external ear

DEVICEpercutaneous electrical nerve-field stimulation, PENFS (sham device)

A novel, FDA approved for commercial use, cleared device that delivers field stimulation with alternating frequencies to the external ear. The sham device will not deliver field stimulation to the ear.

DEVICEpercutaneous electrical nerve-field stimulation, PENFS (COVID active device)

A novel, FDA approved for commercial use, cleared device that delivers field stimulation with alternating frequencies to the external ear


Locations(1)

CHOC Children's

Orange, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04978571


Related Trials